ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 237 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,623,000 | -53.0% | 28,221 | -69.9% | 0.01% | -54.5% |
| Q3 2021 | $5,575,000 | +13.9% | 93,610 | +30.4% | 0.01% | +10.0% |
| Q2 2021 | $4,894,000 | -0.1% | 71,770 | +1.7% | 0.01% | -9.1% |
| Q1 2021 | $4,899,000 | -12.8% | 70,600 | -3.5% | 0.01% | -15.4% |
| Q4 2020 | $5,620,000 | +15.4% | 73,156 | +12.3% | 0.01% | 0.0% |
| Q3 2020 | $4,871,000 | +15.5% | 65,127 | -2.8% | 0.01% | 0.0% |
| Q2 2020 | $4,216,000 | +50.8% | 66,982 | +0.6% | 0.01% | +30.0% |
| Q1 2020 | $2,796,000 | -7.3% | 66,564 | +0.3% | 0.01% | +11.1% |
| Q4 2019 | $3,015,000 | +10.9% | 66,393 | +11.8% | 0.01% | +12.5% |
| Q3 2019 | $2,718,000 | -19.5% | 59,379 | +3.0% | 0.01% | -20.0% |
| Q2 2019 | $3,378,000 | +32.5% | 57,628 | +1.3% | 0.01% | +25.0% |
| Q1 2019 | $2,550,000 | +17.7% | 56,890 | +2.3% | 0.01% | 0.0% |
| Q4 2018 | $2,167,000 | -15.1% | 55,633 | +0.4% | 0.01% | 0.0% |
| Q3 2018 | $2,551,000 | -5.8% | 55,430 | -10.8% | 0.01% | -11.1% |
| Q2 2018 | $2,708,000 | +24.7% | 62,110 | +13.0% | 0.01% | +28.6% |
| Q1 2018 | $2,171,000 | – | 54,974 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |